Data / Drug companies / Zinc oxide, octinoxate
Zinc oxide, octinoxate: 9 companies and 15 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Zinc oxide, octinoxate is listed in the FDA National Drug Code Directory by 9 companies, with 15 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; gel; lotion, and the newest product started marketing on May 20, 2026.
The request: Get every company that lists zinc oxide, octinoxate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 9
- Products
- 15
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Topical, Cutaneous
- Brand names
- Broad Spectrum SPF45, Matte Universal Tinted Moisturizer SPF46, Dr.Denese SPF 30 Defense Day, Clear Defense SPF 45, Hydro Essence Broad Spectrum Sunscreen SPF 40, Sheer Defense Tinted Broad Spectrum Sunscreen SPF 50, Tinted Moisturizer SPF 46 Universal Tint, Essential Moisturizing Sunscreen
- openFDA record search
- api.fda.gov
Companies that list zinc oxide, octinoxate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Drmtlgy, LLC | 4 | cream; gel | Over the counter monograph drugs | May 1, 2025 |
| Private Label Skin Care | 4 | cream | Over the counter monograph drugs | May 20, 2026 |
| I World LLC | 1 | cream | Over the counter monograph drugs | December 17, 2025 |
| Longway Technology(Guangzhou)Co.,Ltd. | 1 | lotion | Over the counter monograph drugs | January 15, 2026 |
| Nippon Shikizai, Inc. | 1 | cream | Over the counter monograph drugs | April 10, 2018 |
| Skin Medicinals LLC | 1 | cream | Over the counter monograph drugs | May 1, 2025 |
| SkinScience Labs, Inc | 1 | cream | Over the counter monograph drugs | May 21, 2011 |
| Topiderm, Inc. | 1 | lotion | Over the counter monograph drugs | January 9, 2021 |
| Vi Medical Products, Inc | 1 | cream | Over the counter monograph drugs | March 26, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 11 | 73.3% |
| Gel | 2 | 13.3% |
| Lotion | 2 | 13.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 15 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 11 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.